A survey of clinician attitudes and management practices in hypertension

Journal of Human Hypertension

Volumn 11, Issue 7, 1997, Pages 413-419

  McAlister, F A ^a,b,c   Laupacis, A ^b   Teo, K K ^a   Hamilton, P G ^a   Montague, T J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Hypertension; Practice patterns; Survey

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; GLUCOSE;

ARTICLE; BORDERLINE HYPERTENSION; CANADA; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; QUESTIONNAIRE; SODIUM RESTRICTION; WEIGHT REDUCTION;

EID: 0030844867     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000457     Document Type: Article

References (46)

1. Collins R et al. Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
2. Isles CG et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986; 4: 141-156.
3. Lindholm L, Ejlertsson G, Schersten B. High risk of cerebro-cardiovascular morbidity in well-treated male hypertensives. A retrospective study of 40-59 year old hypertensives in a Swedish primary care district. Acta Med Scand 1984; 216: 251-259.
4. Bulpitt CJ et al. The survival of treated hypertensive patients and their cause of death. A report from the DHSS Hypertensive Care Computing Project (DHCPP). J Hypertens 1986; 4: 93-99.
5. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993; 153: 154-183.
6. Haynes RB et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. Can Med Assoc J 1993; 149(4): 409-418.
7. Ogilvie RI et al. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. Can Med Assoc J 1993; 149(5): 575-583.
8. Jackson R et al. Management of raised blood pressure in New Zealand: a discussion document. Br Med J 1993; 307: 107-110.
9. Guidelines Sub-committee. 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11: 905-918.
10. Gifford RW, Kirkendall W, O'Connor DT, Weidman W. Office evaluation of hypertension: a statement for health professionals by a writing group of the council for high blood pressure research, American Heart Association. Hypertension 1989; 13: 283-293.
11. Sever P et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J 1993; 306: 983-987.
12. Chockalingam A et al. Recommendations of the Canadian consensus conference on non-pharmacological approaches to the management of high blood pressure. Can Med Assoc J 1990; 142: 1397-1409.
13. Lins RL et al. 1995 survey on the management of hypertension in Belgium [Abstract P1027]. 16th Scientific Meeting of the International Society of Hypertension, Glasgow, Scotland. 23-27 June 1996.
14. Ribacke M. Treatment preferences, return visit planning and factors affecting hypertension practice amongst general practitioners and internal medicine specialists (The General Practitioner Hypertension Practice Study). J Int Med 1995; 237: 473-478.
15. Weiland SK et al. Diagnosis and management of hypertension by physicians in the Federal Republic of Germany. J Hypertens 1991; 9: 131-134.
16. Fotherby MD, Harper GD, Potter JF. General practitioners' management of hypertension in elderly patients. Br Med J 1992; 305: 750-752.
17. Steven ID et al. South Australian hypertension survey. General practitioners experiences with drug treatment. Med J Aust 1992; 156: 641-644.
18. Jerome M et al. Initial medication selection for treatment of hypertension in an open-panel HMO. J Am Board Fam Pract 1995; 8: 1-6.
19. Kofron PM et al. Physician practice for cardiovascular disease risk-factor reduction in six upper Midwestern communities. J Fam Pract 1991; 32: 49-55.
20. Cloher TP, Whelton PK. Physician approach to the recognition and initial management of hypertension. Results of a statewide survey of Maryland physicians. Arch Intern Med 1986; 146: 529-533.
21. Fortmann SP, Sallis JF, Magnus PM, Farquhar JW. Attitudes and practices of physicians regarding hypertension and smoking: The Stanford Five City Project. Prev Med 1985; 14: 70-80.
22. Kawachi I, Malcolm LA, Purdie G. Variability in antihypertensive drug therapy in general practice: results from a random national survey. NZ Med J 1989; 102: 307-309.
23. Steven ID et al. South Australian hypertension survey. General practitioner knowledge and reported management practices - a cause for concern? Med J Aust 1992; 156: 423-428.
24. Troein M et al. Reported treatment of hypertension by family physicians in Sweden and Minnesota: a physician survey of practice habits. J Int Med 1995; 238: 215-221.
25. Ribacke M. The concept of individualized hypertension care in general practice and outpatient clinics. The general practitioner hypertension practice study (III). Scand J Prim Health Care 1995; 13(2): 112-117.
26. Wilhelmsen L, Strasser T. WHO-WHL Hypertension Management Audit Project. J Hum Hypertens 1993; 7(3): 257-263.
27. Chalmers J. Guidelines and consensus statements: their use and impact. J Hum Hypertens 1995; 9: 37-40.
28. Swales JD. Guidelines on guidelines. J Hypertens 1993; 11: 899-903.
29. Levine SR. 'True' diastolic blood pressure. N Engl J Med 1981; 304: 362-363.
30. Myers MG, Reeves RA, Oh PI, Joyner CD. Overtreatment of hypertension in the community? Am J Hypertens 1996; 9: 419-425.
31. Haynes RB et al. Increased absenteeism from work after detection and labelling of hypertensive patients. N Engl J Med 1978; 299: 741-744.
32. Johannesson M, Brgquist L, Jonsson B, Rastam L. The costs of treating hypertension: an analysis of different cut-off points. Health Policy 1991; 18: 141-150.
33. Rosser WW. Using the perception-reality gap to alter prescribing patterns. J Med Educ 1983; 58: 728-732.
34. Lomas J et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989; 321: 1306-1311.
35. Holmes M et al. Methods of analyzing physician practice patterns in hypertension. Med Care 1989; 27: 59-68.
36. White R, Quimby B, Skipper B, Webster G. Cost of residents' decisions on actual patients and in simulated encounters. J Med Educ 1984; 59: 833-835.
37. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700-705.
38. Kosecoff J et al. Effects of the national institutes of health consensus development program on physician practice. JAMA 1987; 258: 2708-2713.
39. Brook RH. Implementing medical guidelines. Lancet 1995; 346: 132.
40. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342: 1317-1322.
41. Manolio TA et al. Trends in pharmacologic management of hypertension in the United States. Arch Inter Med 1995; 155: 829-837.
42. Psaty BM et al. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study. JAMA 1993; 270: 1837-1841.
43. Glynn RJ et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med 1995; 155: 1855-1860.
44. Psaty BM et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-625.
45. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-1331.
46. Opie LH, Messerli FH. Nifedipine and mortality: grave defects in the Dossier. Circulation 1995; 92: 1068-1073.